Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole therapeutic drug monitoring trial in invasive fungal disease
NL-OMON40059Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of voriconazole in invasive aspergillosis (IA) and invasive mycoses (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Global response at day 28. Started May 2009; status: active, not recruiting.
02
Drugs
voriconazole
03
Conditions
invasive aspergillosis (IA)invasive mycoses
Beyond the preview
Go deeper on NL-OMON40059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40059.